- /
- Supported exchanges
- / US
- / IRMD.NASDAQ
Iradimed Co (IRMD NASDAQ) stock market data APIs
Iradimed Co Financial Data Overview
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Iradimed Co (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Iradimed Co data using free add-ons & libraries
Get Iradimed Co Fundamental Data
Iradimed Co Fundamental data includes:
- Net Revenue: 86 338 K
- EBITDA: 29 184 K
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-07-31
- EPS/Forecast: 0.42
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Iradimed Co News
New
IRadimed anticipates Q3 revenue of $23M-$24.5M as 3870 pump production ramps to over 300 units
Earnings Call Insights: IRadimed (IRMD) Q2 2026 MANAGEMENT VIEW * “This quarter, we embarked on the first general release production of the new 3870 MR IV pump system as planned, targeting... th...
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline
Riverwater Partners, an investment management company, released its "Micro Opportunities Strategy" Q2 2026 investor letter. A copy of the letter is available to download here. In Q2 2026, the Micro Op...
Can IradiMed Extend Its Earnings Momentum In Q2 2026, Will Device Sales Continue To Climb?
(RTTNews) - IRADIMED CORPORATION (IRMD), a medical device company, announced Friday that it will release its results for the second quarter of fiscal 2026 before the market opens on July 31, 2026. The...
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens o...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.